Health and Fitness Health and Fitness
Tue, January 21, 2025

Study reveals GLP-1 drugs' benefits and risks for users


Published on 2025-01-21 16:03:18 - MSN
  Print publication without navigation

  • A study by Washington University School of Medicine and the VA St. Louis Health Care System has found that GLP-1 drugs can have both health benefits and risks, including reduced risks of Alzheimer's,

The article from MSN discusses a study on GLP-1 drugs, which are primarily used for managing type 2 diabetes and have been noted for their weight loss benefits. These drugs, including popular names like Ozempic and Wegovy, mimic the effects of the GLP-1 hormone, which helps in reducing appetite and increasing insulin secretion. The study highlights both the benefits and risks associated with these medications. Benefits include significant weight loss, improved blood sugar control, and potential cardiovascular benefits. However, there are also notable risks such as gastrointestinal issues like nausea, vomiting, and diarrhea, as well as more severe concerns like pancreatitis, gallbladder disease, and potential thyroid tumors. The study also touches on the off-label use of these drugs for weight loss, which has led to shortages for diabetic patients, and emphasizes the need for careful patient selection and monitoring due to these side effects.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/diseases-and-conditions/study-reveals-glp-1-drugs-benefits-and-risks-for-users/ar-AA1xBY0H ]
Contributing Sources